Deal struck to produce over 100 million vaccines for future flu pandemic

A Liverpool company has secured a deal to produce over 100 million vaccines in the event of a future flu pandemic.
The UK Health Security Agency (UKHSA) has agreed an advance purchase agreement with healthcare company CSL Seqirus.
The firm is already one of the world’s biggest flu vaccine manufacturers but the deal would supply the volume of doses needed during a pandemic.
READ MORE: Click here to sign up to the BusinessLive North West newsletter
READ MORE: THG Ingenuity boss on Matthew Moulding, doubling down and shareholder opinions
The UKHSA said this is the first time the manufacturing process would be based entirely in the UK, ensuring access to vaccines if the global demand outweighs supply.
In December 2020, UK grandmother Margaret Keenan became the first person in the world to be given the Pfizer Covid-19 jab thanks to agreements made on procuring coronavirus vaccines.
The new vaccines would be developed and tested to match the pandemic flu strain circulating at the time, with the jabs made at CSL Seqirus’s existing manufactur …